Radiology, Radiation Oncology · Merced, CA
NPI
1720166309
Since 2006
Specialty
Radiology, Radiation Oncology
Code 2085R0001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3303 M St
Merced, CA, 95348
Phone (209) 726-3410
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
20,029 services
Medicare patients, 2024
402
Average age 72
Drug cost, 2024
$4.2M
1,333 prescriptions
Company payments, 2025
$2,879
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alireza Mahmoudieh was code G6015 (intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session), 1,719 times for 52 patients. In total Alireza Mahmoudieh billed 20,029 services in 107 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 1,719 | 52 | $328.12 | $564K |
| 77014 Conventional Radiation Treatment | Office | 1,713 | 49 | $108.03 | $185K |
| 99214 Office E&M - Established | Office | 707 | 276 | $104.21 | $74K |
| 77768 Conventional Radiation Treatment | Office | 587 | 21 | $333.42 | $196K |
| 77280 Radiation Treatment Planning | Office | 558 | 21 | $246.66 | $138K |
| 77336 Radiation Treatment Planning | Office | 488 | 73 | $81.15 | $40K |
| 77427 Conventional Radiation Treatment | Office | 297 | 48 | $164.44 | $49K |
| 96367 Intravenous Infusion, Hydration | Office | 171 | 25 | $24.71 | $4,226 |
| 99205 Office E&M - New | Office | 133 | 133 | $176.71 | $24K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 119 | 25 | $0.23 | $27.7 |
| J1750 Injection, iron dextran, 50 mg | Office | 115 | 14 | $8.46 | $973 |
| 96365 Intravenous Infusion, Hydration | Office | 114 | 30 | $55.78 | $6,359 |
| 96413 Chemotherapy Administration | Office | 95 | 14 | $110.41 | $10K |
| 77334 Radiation Treatment Planning | Office | 84 | 74 | $111.90 | $9,399 |
| 77300 Radiation Treatment Planning | Office | 84 | 55 | $58.37 | $4,903 |
By year: 2022 $1.3M for 26,194 services; 2023 $1.4M for 29,567 services; 2024 $2.0M for 20,029 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alireza Mahmoudieh prescribed most often to Medicare patients was Abiraterone Acetate, with 96 prescriptions and refills. In total Alireza Mahmoudieh wrote 1,333 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 96 | 96 | 14 | $290K |
| Prednisone Generic | 91 | 99 | 15 | $237 |
| Cephalexin Generic | 46 | 46 | 46 | $151 |
| Dexamethasone Generic | 45 | 48 | Under 11 | $558 |
| Tamsulosin Hcl Generic | 43 | 86 | 18 | $572 |
| Anastrozole Generic | 42 | 120 | 14 | $726 |
| Dexamethasone Sodium Phosphate Generic | 40 | 42 | Under 11 | $134 |
| Diphenhydramine Hcl Generic | 39 | 41 | Under 11 | $99.32 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 37 | 37 | 26 | $752 |
| Ondansetron Hcl Generic | 36 | 53 | 23 | $770 |
| Revlimid Lenalidomide | 31 | 31 | Under 11 | $577K |
| Clobetasol Propionate Generic | 28 | 30 | 11 | $1,565 |
| Keytruda Pembrolizumab | 27 | 27 | Under 11 | $292K |
| Ondansetron Hcl Ondansetron Hcl/Pf | 27 | 28 | Under 11 | $123 |
| Lenalidomide Generic | 25 | 25 | Under 11 | $304K |
Brand drugs: 325 claims; generic drugs: 1,008 claims; opioid claims: 69.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alireza Mahmoudieh $2,879 ($2,879 in general payments such as food, travel and fees) from 40 companies. The largest payer was Novartis Pharmaceuticals Corporation with $641.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 14 | $641 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $234 |
| Daiichi Sankyo Inc. 4568.T | 5 | $198 |
| Merck Sharp & Dohme LLC MRK | 6 | $139 |
| Dendreon Pharmaceuticals LLC | 1 | $125 |
| Incyte Corporation INCY | 6 | $113 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $109 |
| Janssen Biotech, Inc. JNJ | 4 | $103 |
| Novocure Inc. NVCR | 3 | $73.9 |
| Siemens Medical Solutions USA, Inc. SHL.DE | 1 | $73.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.